Praesidium Investment Management Company Llc bought 283,968 shares as the company's stock declined 0.96% while stock markets rallied. Ironwood Investment Management Llc who had been investing in Progress Software Corp for a number of months, seems to be less bullish one the $2.43B market cap company. The stock was trading at a distance of -2.78% from its 52-week highs and stands 53.12% away from its 52-week lows. About 1.11M shares traded.
Shares of Progress Software (NASDAQ:PRGS) opened at 28.45 on Tuesday. It has underperformed by 1.65% the S&P500. That's a potential 158.97 increase relative to where TG Therapeutics, Inc. The company had revenue of $116.30 million during the quarter, compared to the consensus estimate of $114.33 million. About 8.70M shares traded. eBay Inc. BorgWarner Inc. (NYSE:BWA) has risen 25.00% since January 12, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.
Checking the amount of enthusiasm that Wall Street analysts hold for a particular stock is crucial when thinking about entering a position. The stock of Epizyme, Inc. The mean target price as estimated by the analysts for the company has been recorded at $23.81. The rating was reinitiated by UBS with "Buy" on Wednesday, January 11. The firm earned "Buy" rating on Wednesday, January 18 by Benchmark. (NASDAQ:PRGS) from a hold rating to a buy rating in a research note published on Tuesday morning. Ladenburg Thalmann downgraded the shares of PRGS in report on Tuesday, September 13 to "Neutral" rating. As per Thursday, April 14, the company rating was maintained by JP Morgan.
Accenture Plc (ACN) CAO Richard P. Clark Sells 1433 Shares
Voya Invest Limited Liability Company has 55,489 shares for 0% of their portfolio. 1,481 were accumulated by At Bankshares. Manchester Capital Management LLC increased its holdings in shares of Accenture by 7.0% during the second quarter.
Investors sentiment decreased to 1.14 in 2017 Q3. Its down 0.16, from 0.89 in 2017Q2. It worsened, as 17 investors sold PRGS shares while 69 reduced holdings. 37 funds opened positions while 61 raised stakes. Its down 1.61% from 5.75 million shares previously. Ibm Retirement Fund stated it has 0.26% of its portfolio in The Charles Schwab Corporation (NYSE:SCHW). Thrivent For Lutherans holds 244,912 shares or 0.03% of its portfolio. Deutsche Bank & Trust Ag has 76,730 shares. Bb&T Ltd stated it has 0% in Epizyme, Inc. Jgp Global Gestao De Recursos Ltda reported 0.3% of its portfolio in Epizyme, Inc. (NASDAQ:EBAY). Cohen Klingenstein Lc stated it has 9,200 shares or 0.05% of all its holdings. Moreover, Invesco Limited has 0% invested in Epizyme, Inc. (NASDAQ:EBAY). Landscape Management Llc invested in 44,333 shares. Price T Rowe Assoc Inc Md accumulated 14,712 shares. Tci Wealth Incorporated holds 0.01% or 282 shares in its portfolio. Parametric Portfolio Associates invested in 0.01% or 164,734 shares. (NASDAQ:EPZM). State Street Corp has invested 0% in Epizyme, Inc. (NASDAQ:EBAY). Fny Managed Accounts Llc holds 0.02% or 520 shares in its portfolio. On Monday, September 18 MOTT DAVID M bought $3.05M worth of Epizyme, Inc. EPZM's SI was 5.66M shares in January as released by FINRA. (NASDAQ:EPZM). Jacobs Levy Equity Mgmt owns 13,390 shares. Analysts have a mean recommendation of 2.80 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range). Therefore 92% are positive. Epizyme had 29 analyst reports since August 6, 2015 according to SRatingsIntel. On Friday, October 2 the stock rating was maintained by Wedbush with "Neutral". The company was maintained on Friday, October 2 by Wedbush. The firm has "Buy" rating by Benchmark given on Friday, January 15. The rating was maintained by Benchmark with "Buy" on Wednesday, January 18. (NASDAQ:EPZM) on Wednesday, June 14 with "Buy" rating. Argus reiterated a hold rating on shares of Progress Software in a research note on Friday, December 30th. Progress Software Corporation (NASDAQ:PRGS) has risen 15.05% since January 12, 2017 and is uptrending.
Progress Software (NASDAQ:PRGS) last posted its quarterly earnings results on Wednesday, January 10th.
Over the past five trading sessions shares of Envision Healthcare Corporation (NYSE:EVHC) are 1.27%; 8.97% for the month; -14.32% for the last quarter; -41.52% for the past six-months; and -46.48% for the last 12 months. PRGS's profit will be $25.82 million for 23.64 P/E if the $0.54 EPS becomes a reality. The company reported $0.62 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.56 by $0.06.